Daratumumab and isatuximab show comparable efficacy in newly diagnosed multiple myeloma
Daratumumab and isatuximab show comparable efficacy in newly diagnosed multiple myeloma
Arcotatug tavatecan improves progression-free survival in CLDN18.2-positive advanced gastric cancer
Divarasib improves survival in previously treated KRAS G12C mutated advanced NSCLC
ESMO 2026: Highlights and analysis
HBI-8000 plus nivolumab significantly improves progression-free survival in advanced melanoma
TALENT: Neoadjuvant T-DXd with or without anastrozole, or in sequence with chemo for HER2-low, HR+ early-stage breast cancer
Extended letrozole improves disease-free survival in hormone receptor-positive breast cancer: 15-year results
Building the cancer system of the future in UAE
Zidesamtinib shows promising efficacy in TKI-naïve ROS1-positive advanced NSCLC
Subcutaneous tarlatamab shows promising safety and activity in previously treated extensive-stage SCLC
Acyclovir prophylaxis reduces varicella infections in children receiving intensive chemotherapy
Triplet regimen of amivantamab, lazertinib, and pemetrexed showed robust efficacy in advanced EGFR-mNSCLC